Homepage
Contacts

AMIT 2007 \ Programme

Registration of Participants
08.00-09.00

Opening remarks
09.00-09.30

Message from the Congress President
M. Tinelli

Messages from the Public Authorities

Keynote Lecture
09.30-10.30
State of the Art in the Use of Antibiotics: Present and Future - S. Zinner (Boston, USA)

Session 1
10.30-11.15
Epidemiology and Resistance
Chairpersons: E. Magliano (Milan), L. Pagani (Pavia)

Epidemiology of Multiresistant Gram-Negative Infections: ESBL, MBL, Pan-Resistant Strains -G.M. Rossolini (Siena)

Epidemiology of Multiresistant Gram-Positive Infections: MRSA, VISA, VRSA, VRE - G. Gesu (Milan)

Discussion

Coffee break
11.15-11.30

Session 2
11.30-13.30
Emerging Problems with Infections: Questions and Answers
Chairpersons: G. Carosi (Brescia), E. Concia (Verona)

Are Transplant Patients the First to Pay the Price of Increased Resistance to Antibiotics? - P. Grossi (Varese)

Which Is the Best Choice of Therapy in Intensive Care: Continuous, Bolus or Cyclical Infusion? - A. De Gasperi (Milan)

Are Long-Stay Hospital Wards and Community Facilities Now at Higher Risk of Resistance to Antibiotics? - S. Esposito (Naples)

Is Community-Acquired Methicillin-Resistant Staphylococcus Aureus (CA-MRSA) Really an Emerging Risk in Clinical Practice? - M. Tinelli (Lodi)

Treatment of Patients at Risk of Invasive Fungal Infections: How and What Should We Do? - C. Viscoli (Genoa)

Discussion

Poster Session
13.30-14.45

Lunch
13.30-14.45

Session 3
14.45-16.00

New Therapeutic Opportunities
Chairpersons: R. Cauda (Rome), F. De Lalla (Vicenza)

New Antibiotics and Their Use With Emerging Highly Antibiotic-Resistant Bacterial Strains - E. Concia (Verona)

Pharmacokinetic-Pharmacodynamic Criteria for Optimising Antibiotic Therapy - F. Pea (Udine)

Discussion

Coffee break
16.00-16.15

Session 4
16.15-18.00

Oral Communications
Chairpersons: F. Mazzotta (Florence), L. Minoli (Pavia)

Keynote Lecture 0
9.15-10.15

Hospital Infections: the State of the Art - L. Mermel (Providence, USA)

Coffee break
10.15-10.30

Session 5
10.30-12.30

Round Table: Strategies for the Prevention of Infections
Chairpersons: L. Macchi (Milan), G. Rezza (Rome)

The Role of the European Centre for Disease Control (ECDC) in the Prevention and Management of Infectious Diseases - P. Tull (Stockholm)

Prevention and Control of Emerging Infections: a Challenge for the Third Millennium - G. Rezza (Rome)

Should the Concept of Prevention of Communicable Diseases Still Consider Nosocomial and Community-Acquired Infections Separately or Are Changes Underway? - M.L. Moro (Bologna)

Experience To Date and Projects Being Implemented for the Prevention of Infection in the Region of Lombardy - A. Pavan (Milan)

Discussion

Poster Session

Lunch
13.00-14.00

Session 6
14.00-16.00

Round Table: Risk Management in Infectious Diseases
Chairpersons: G. Ippolito (Rome), C. Signorelli (Parma)

Risk Management in Infectious Diseases: General Considerations - G. Ippolito (Rome)

Management of the Risk of Infection Upon Admission: New Protocols - P.L. Viale (Udine)

Risk Management in Emergency Situations - N. Petrosillo (Rome)

Professional Responsibility in Nosocomial and Community-Acquired Infections - A. Marra (Milan)

Insurance Cover for Risks Relating to Nosocomial and Community-Acquired Infections - A. Steffano (Milan)

Discussion

Coffee break
16.00-16.15

Session 7
16.15-17.15

Antibiotics and HIV
Chairpersons: M. Galli (Milan), G. Filice (Pavia)

Interaction Between Antiretroviral Drugs and Antibiotics - G. Di Perri (Turin)

Pharmacokinetics and Pharmacodynamics in HAART and Antibiotic Therapy - M. Boffito (London)

Discussion

Final Remarks and Compilation of ECM Questionnaire